Published Online: Monday, October 1, 2007

Officials at the Centers for Medicare & Medicaid Services (CMS) are crediting the strong emphasis on cost-effective generic drugs with driving down the anticipated cost of Medicare Part D prescription drug coverage premiums for the coming year.

According to CMS, the actual average premium paid by beneficiaries for standard Part D coverage in 2008 will be roughly $25-an amount that is nearly 40 percent lower than originally projected when the benefit was established in 2003, and also lower than was projected earlier this year.

"Smart choices" have played a key role, according to CMS Acting Deputy Administrator Herb B. Kuhn. "Medicare drug benefit bids continue to be well below projections because of?increased generic usage," he said. Kuhn also credited "effective plan negotiation" for lower prices from pharmaceutical manufacturers, as well as "strong competition" among the drug plans themselves.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues